These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 11864504

  • 1. [A study on immunogenicity and safety of bivalent inactivated vaccine against hemorrhagic fever with renal syndrome].
    Ruan Y, Xu X, Liu W, Deng X, Weng S, Zhou W, Wang Q, Chen L, Fang L, Xu Z, Yan Q, Liu W, Dong G, Gu H, Yu Y, Xu Z.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov; 33(6):340-2. PubMed ID: 11864504
    [Abstract] [Full Text] [Related]

  • 2. [Safety and immunogenicity of inactivated bivalent EHF vaccine in humans].
    Liu W, Xu X, Ruan Y, Weng S, Liu W, Zhou W, Dong G, Gu H, Zhu Z, Xu Z.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):445-7. PubMed ID: 11860832
    [Abstract] [Full Text] [Related]

  • 3. [Comparative study on antibody levels of vaccination group and control group after 4 years of immunized with type B inactivated vaccine against hemorrhagic fever with renal syndrome].
    Ruan Y, Liu W, Xu X, Weng SQ, Shao SK, Zhou WQ, Teng Z, Gu HX, Zhu ZY, Xu ZY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):274-6. PubMed ID: 11986705
    [Abstract] [Full Text] [Related]

  • 4. [Serological surveillance on vaccine against hemorrhagic fever with renal syndrome].
    Gong ZY, Weng JQ, Zhao ZY, Chen YT, Zhu AG, Fu GM, Fang CF, Zhu ZY, Chen EF, Wang CZ, Wang W, Lei LH, Wang Z.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):400-2. PubMed ID: 15231163
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of HFRS vaccination against hemorrhagic fever with renal syndrome during 1999-2000 in Laiwu City].
    Wei K, Xie Y, Yao Z.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):283-5. PubMed ID: 12665942
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of subclinical infection rates between vaccinated group with type I inactivated vaccine against hemorrhagic fever and controls].
    Ruan Y, Xu X, Shao S, Tong Z, Weng S, Zhou W, Gu H, Zhu Z, Xu Z.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):308-10. PubMed ID: 11864500
    [Abstract] [Full Text] [Related]

  • 7. Investigation on inactivated epidemic hemorrhagic fever tissue culture vaccine in humans.
    Zhu ZY, Tang HY, Li YJ, Weng JQ, Yu YX, Zeng RF.
    Chin Med J (Engl); 1994 Mar; 107(3):167-70. PubMed ID: 7916278
    [Abstract] [Full Text] [Related]

  • 8. [Preventive effects of three kinds of inactive vaccines against epidemic hemorrhagic fever (EHF) after 5 years of vaccination].
    Chen H, Tang L, Luo Z, Zhang J, Zhang Z, Hu M, Weng J, Liu W, Zhao T, Liu W.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Oct; 21(5):347-8. PubMed ID: 11860813
    [Abstract] [Full Text] [Related]

  • 9. [Passage adaptability of candidate strains for hemorrhagic fever with renal syndrome purified vaccine in Vero cells and their immunogenicity].
    Chen W, Xue CF, Liu JQ, Li ZY, Fan YX, Xu L, Liao H.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):129-32. PubMed ID: 12869992
    [Abstract] [Full Text] [Related]

  • 10. [The changes in serum antibody level after immunization with HFRS vaccine].
    Gong Z, Weng J, Zhao Z, Lan J, Chen Y, Lin C, Fu G, Zhu Z, Xia J, Ji Q, Xu J, Wang C, Yu X, Wang W, Fang C.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Nov; 34(6):351-3. PubMed ID: 11860948
    [Abstract] [Full Text] [Related]

  • 11. Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults.
    Song JY, Woo HJ, Cheong HJ, Noh JY, Baek LJ, Kim WJ.
    Vaccine; 2016 Mar 04; 34(10):1289-95. PubMed ID: 26826547
    [Abstract] [Full Text] [Related]

  • 12. Immunization effect of purified bivalent vaccine to haemorrhagic fever with renal syndrome manufactured from primary cultured hamster kidney cells.
    Dong GM, Han L, An Q, Liu WX, Kong Y, Yang LH.
    Chin Med J (Engl); 2005 May 05; 118(9):766-8. PubMed ID: 15899141
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
    Boudreau EF, Josleyn M, Ullman D, Fisher D, Dalrymple L, Sellers-Myers K, Loudon P, Rusnak J, Rivard R, Schmaljohn C, Hooper JW.
    Vaccine; 2012 Mar 02; 30(11):1951-8. PubMed ID: 22248821
    [Abstract] [Full Text] [Related]

  • 15. [Progress in the epidemiologic study of hemorrhagic fever with renal syndrome in China in recent years].
    Wu GH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May 02; 24(5):413-5. PubMed ID: 15481132
    [No Abstract] [Full Text] [Related]

  • 16. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
    Hooper JW, Moon JE, Paolino KM, Newcomer R, McLain DE, Josleyn M, Hannaman D, Schmaljohn C.
    Clin Microbiol Infect; 2014 May 02; 20 Suppl 5():110-7. PubMed ID: 24447183
    [Abstract] [Full Text] [Related]

  • 17. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 02; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 18. Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters.
    Spik KW, Badger C, Mathiessen I, Tjelle T, Hooper JW, Schmaljohn C.
    Vaccine; 2008 Sep 19; 26(40):5177-81. PubMed ID: 18482782
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J, Fang HH, Chen JT, Zhou JC, Feng ZJ, Li CG, Qiu YZ, Liu Y, Lu M, Liu LY, Dong SS, Gao Q, Zhang XM, Wang N, Yin WD, Dong XP.
    Clin Infect Dis; 2009 Apr 15; 48(8):1087-95. PubMed ID: 19281330
    [Abstract] [Full Text] [Related]

  • 20. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
    Li Z, Zeng H, Wang Y, Zhang Y, Cheng L, Zhang F, Lei Y, Jin B, Ma Y, Chen L.
    Hum Vaccin Immunother; 2017 Apr 03; 13(4):802-807. PubMed ID: 27824286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.